Copertina

Relative cerebral blood volume is a potential predictive imaging biomarker of bevacizumab efficacy in recurrent glioblastoma

To analyze the relevance of dynamic susceptibility-weighted contrast-enhanced MRI (DSC-MRI) derived relative cerebral blood volume (rCBV) analysis for predicting response to bevacizumab (BEV) in patients with recurrent glioblastoma (rGB).

Salvato in:
Dettagli Bibliografici
Autori principali: Vollmuth, Philipp (Autore) , Wiestler, Benedikt (Autore) , Burth, Sina (Autore) , Wick, Antje (Autore) , Nowosielski, Martha (Autore) , Heiland, Sabine (Autore) , Schlemmer, Heinz-Peter (Autore) , Wick, Wolfgang (Autore) , Bendszus, Martin (Autore) , Radbruch, Alexander (Autore)
Natura: Article (Journal)
Lingua:inglese
Pubblicazione: 9 March 2015
In: Neuro-Oncology
Year: 2015, Volume: 17, Fascicolo: 8, Pages: 1139-1147
ISSN:1523-5866
DOI:10.1093/neuonc/nov028
Accesso online:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1093/neuonc/nov028
Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/neuro-oncology/article/17/8/1139/2324944
Testo
Note sull'autore:Philipp Kickingereder, Benedikt Wiestler, Sina Burth, Antje Wick, Martha Nowosielski, Sabine Heiland, Heinz-Peter Schlemmer, Wolfgang Wick, Martin Bendszus, and Alexander Radbruch
Descrizione
Riassunto:To analyze the relevance of dynamic susceptibility-weighted contrast-enhanced MRI (DSC-MRI) derived relative cerebral blood volume (rCBV) analysis for predicting response to bevacizumab (BEV) in patients with recurrent glioblastoma (rGB).
Descrizione del documento:Gesehen am 29.06.2020
Descrizione fisica:Online Resource
ISSN:1523-5866
DOI:10.1093/neuonc/nov028

Documenti analoghi